BioMed Research International

Regenerative Medicine


Publishing date
28 Feb 2014
Status
Published
Submission deadline
11 Oct 2013

1Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Osaka, Japan

2Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Osaka, Japan

3Department of Cardiovascular Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan

4William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK

5Brigham and Women’s Hospital, Harvard Medical School, 3 Blackfan Street, 17th Floor, Boston, MA, USA

6Department of Ophthalmology, Graduate School of Medicine, Osaka University, Osaka, Japan


Regenerative Medicine

Description

Regenerative medicine would be the most exciting area in recent scientific topics. In the history of human gene therapy, the severe combined immunodeficiency caused by the absence of adenosine deaminase (SCID-ADA) was the first monogenic disorder for which gene therapy was developed in 1990. Over 30 patients have been treated worldwide using the current protocols, and recent trials provided the demonstration of long-term clinical efficacy of HSC gene therapy for SCID-ADA in combination with gene and cell therapy. We have now several options, such as gene therapy and/or cell therapy with advanced technology (i.e., cell sheet or drug delivery system), to fight against the severe diseases.

The main focus of this special issue will be on the new and exciting therapy for cardiovascular diseases, cancer, or inflammatory diseases, which includes the range from basic to clinical studies. We will take particular interest in review or original articles for clinical trials or translational research. The special issue will teach us the recent progression in each field which could give us the exciting knowledge and ideas. Potential topics include, but are not limited to:

  • Antiangiogenic therapy for cancer
  • Cell and tissue engineering for heart failure
  • Virosome therapy for cancer
  • Therapeutic angiogenesis for ischemic disease
  • Vaccine for cardiovascular disease
  • Oligodeoxynucleotide therapy
  • Biomaterials and tissue interaction
  • Molecular mechanisms of atherosclerosis
  • Stem cell therapy for heart failure

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/genetics/rm/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 431540
  • - Editorial

Regenerative Medicine

Ryuichi Morishita
  • Special Issue
  • - Volume 2014
  • - Article ID 701571
  • - Review Article

Role of the Vasa Vasorum and Vascular Resident Stem Cells in Atherosclerosis

Jun-ichi Kawabe | Naoyuki Hasebe
  • Special Issue
  • - Volume 2014
  • - Article ID 951512
  • - Review Article

Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols

Chiho Ikebe | Ken Suzuki
  • Special Issue
  • - Volume 2013
  • - Article ID 428247
  • - Review Article

Regenerative Medicine for the Cornea

Yoshinori Oie | Kohji Nishida
  • Special Issue
  • - Volume 2013
  • - Article ID 764706
  • - Review Article

Virosome Presents Multimodel Cancer Therapy without Viral Replication

Kotaro Saga | Yasufumi Kaneda
  • Special Issue
  • - Volume 2013
  • - Article ID 583912
  • - Review Article

Present and Future Perspectives on Cell Sheet-Based Myocardial Regeneration Therapy

Yoshiki Sawa | Shigeru Miyagawa
  • Special Issue
  • - Volume 2013
  • - Article ID 186215
  • - Review Article

Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease

Munehisa Shimamura | Hironori Nakagami | ... | Ryuichi Morishita
  • Special Issue
  • - Volume 2013
  • - Article ID 804675
  • - Review Article

Lymphedema and Therapeutic Lymphangiogenesis

Yukihiro Saito | Hironori Nakagami | ... | Ryuichi Morishita
BioMed Research International
 Journal metrics
Acceptance rate30%
Submission to final decision81 days
Acceptance to publication43 days
CiteScore2.410
Impact Factor2.197
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.